Penumbra Inc. (NYSE:PEN) previous close was $278.32 while the outstanding shares total 36.21M. The firm has a beta of 0.23. PEN’s shares traded lower over the last trading session, losing -0.26% on 02/16/21. The shares fell to a low of $272.925 before closing at $277.60. Intraday shares traded counted 0.21 million, which was 74.63% higher than its 30-day average trading volume of 827.18K. The stock’s Relative Strength Index (RSI) is 68.80, with weekly volatility at 4.43% and ATR at 14.08. The PEN stock’s 52-week price range has touched low of $121.80 and a $314.22 high.
Investors have identified the Medical Devices company Penumbra Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $9.91 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Penumbra Inc. (PEN) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 590.2 million total, with 108.06 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 0.71 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on PEN sounds very interesting.
Is the stock of PEN attractive?
In related news, Chief Innovator, Bose Arani sold 10,000 shares of the company’s stock in a transaction that recorded on Feb 01. The sale was performed at an average price of 259.43, for a total value of 2,594,271. As the sale deal closes, the President, International, Pray James Robert now sold 5,000 shares of the company’s stock, valued at 1,298,199. Also, Chief Innovator, Bose Arani sold 10,000 shares of the company’s stock in a deal that was recorded on Jan 25. The shares were price at an average price of 255.81 per share, with a total market value of 2,558,100. Following this completion of acquisition, the Director, Grewal Harpreet now holds 633 shares of the company’s stock, valued at 110,345. In the last 6 months, insiders have changed their ownership in shares of company stock by 1.80%.
5 out of 7 analysts covering the stock have rated it a Buy, while 2 have maintained a Hold recommendation on Penumbra Inc.. 0 analysts has assigned a Sell rating on the PEN stock. The 12-month mean consensus price target for the company’s shares has been set at $236.80.